Teladoc Health, Inc. Files 2023 Annual Report on Form 10-K

TL;DR

<b>Teladoc Health, Inc. has filed its 2023 Form 10-K, detailing its financial performance and operational status for the fiscal year ending December 31, 2023.</b>

AI Summary

Teladoc Health, Inc. (TDOC) filed a Annual Report (10-K) with the SEC on February 23, 2024. Teladoc Health, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2023. The filing covers the period from January 1, 2023, to December 31, 2023. The company's principal executive offices are located at 2 Manhattanville Road, Suite 203, Purchase, NY 10577. The filing includes financial data for the fiscal year 2023. Teladoc Health, Inc. was formerly known as Teladoc, Inc., with a name change effective November 23, 2009.

Why It Matters

For investors and stakeholders tracking Teladoc Health, Inc., this filing contains several important signals. This 10-K filing provides a comprehensive overview of Teladoc's financial health, operational strategies, and risk factors for the past fiscal year, crucial for investors to assess performance and future outlook. The detailed financial statements and disclosures within the 10-K are essential for understanding the company's revenue streams, profitability, debt levels, and overall market position in the telehealth industry.

Risk Assessment

Risk Level: medium — Teladoc Health, Inc. shows moderate risk based on this filing. The company's financial performance and market position are subject to the dynamic and competitive telehealth industry, which can impact revenue and profitability.

Analyst Insight

Investors should review the detailed financial statements and risk factors in the 10-K to assess Teladoc's ability to navigate market challenges and achieve sustainable growth.

Key Numbers

• 2023-12-31 — Fiscal Year End (Reporting period)
• 2024-02-23 — Filing Date (Date of submission)

Key Players & Entities

• Teladoc Health, Inc. (company) — Filer name
• 2 Manhattanville Road, Suite 203, Purchase, NY 10577 (location) — Business address
• Teladoc, Inc. (company) — Former company name
• 2009-11-23 (date) — Date of name change
• 2023-12-31 (date) — Fiscal year end

FAQ

Industry Context

Teladoc Health operates in the rapidly evolving telehealth and virtual care industry, facing competition and regulatory changes.

Regulatory Implications

The telehealth industry is subject to various healthcare regulations, including those related to patient privacy (HIPAA) and the provision of medical services across state lines.

What Investors Should Do

1. Analyze the detailed financial statements for revenue trends, profitability, and cash flow.
2. Review the risk factors section for potential challenges and management's mitigation strategies.
3. Compare key performance indicators with industry benchmarks and prior year results.

Key Dates

• 2023-12-31: Fiscal Year End — End of the reporting period for the 10-K filing.
• 2024-02-23: Filing Date — Date the 10-K was officially filed with the SEC.

Year-Over-Year Comparison

This filing represents the annual report for the fiscal year 2023, providing updated financial and operational information compared to previous filings.

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share TDOC The New York Stock Excha

Filing Documents

• tdoc-20231231.htm (10-K) — 2196KB
• tdoc-20231231xexx32.htm (EX-3.2) — 233KB
• tdoc-20231231xexx1029.htm (EX-10.29) — 24KB
• tdoc-20231231xexx1037.htm (EX-10.37) — 87KB
• tdoc-20231231xexx1039.htm (EX-10.39) — 87KB
• tdoc-20231231xexx1041.htm (EX-10.41) — 88KB
• tdoc-20231231xexx1042.htm (EX-10.42) — 40KB
• tdoc-20231231xexx211.htm (EX-21.1) — 20KB
• tdoc-20231231xexx231.htm (EX-23.1) — 6KB
• tdoc-20231231xexx311.htm (EX-31.1) — 10KB
• tdoc-20231231xexx312.htm (EX-31.2) — 10KB
• tdoc-20231231xexx321.htm (EX-32.1) — 4KB
• tdoc-20231231xexx322.htm (EX-32.2) — 4KB
• tdoc-20231231xexx971.htm (EX-97.1) — 45KB
• tdoc-20231231_g1.jpg (GRAPHIC) — 41KB
• 0001477449-24-000023.txt (&nbsp;) — 12222KB
• tdoc-20231231.xsd (EX-101.SCH) — 78KB
• tdoc-20231231_cal.xml (EX-101.CAL) — 119KB
• tdoc-20231231_def.xml (EX-101.DEF) — 352KB
• tdoc-20231231_lab.xml (EX-101.LAB) — 1009KB
• tdoc-20231231_pre.xml (EX-101.PRE) — 685KB
• tdoc-20231231_htm.xml (XML) — 1640KB

Business

Business 3 ITEM 1A.

Risk Factors

Risk Factors 18 ITEM 1B. Unresolved Staff Comments 50 ITEM 1C. Cybersecurity 50 ITEM 2.

Properties

Properties 51 ITEM 3.

Legal Proceedings

Legal Proceedings 52 ITEM 4. Mine Safety Disclosures 52 PART II ITEM 5. Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities 52 ITEM 6. Reserved 53 ITEM 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 54 ITEM 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 68 ITEM 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 69 ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 69 ITEM 9A.

Controls and Procedures

Controls and Procedures 69 ITEM 9B. Other Information 72 ITEM 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 72 PART III ITEM 10. Directors, Executive Officers and Corporate Governance 72 ITEM 11.

Executive Compensation

Executive Compensation 72 ITEM 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 72 ITEM 13. Certain Relationships and Related Transactions, and Director Independence 73 ITEM 14. Principal Accounting Fees and Services 73 PART IV ITEM 15. Exhibits and Financial Statement Schedules 74 ITEM 16. Form 10-K Summary 74 EXHIBIT INDEX 75

SIGNATURES

SIGNATURES 80 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA F- 1 ____________________________________ 2 Table of Contents PART I -SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS Many statements made in this Annual Report on Form 10-K that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as "anticipates", "believes", "suggests", "targets", "projects", "plans", "expects", "future", "intends", "estimates", "predicts", "potential", "may", "will", "should", "could", "would", "likely", "foresee", "forecast", "continue" and other similar words or phrases, as well as statements in the future tense to identify these forward-looking statements. These forward-looking statements and projections are contained throughout this Form 10-K, including the sections entitled "Business," "Risk Factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations." Teladoc Health, Inc., together with its subsidiaries, is referred to herein as "Teladoc Health," the "Company," or "we." We base these forward-looking statements or projections on our current expectations, plans and assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances and at such time. As you read and consider this Form 10-K, you should understand that these statements are not guarantees of performance or results. The forward-looking statements and projections are subject to and involve risks, uncertainties and assumptions and you should not place undue reliance o

Business

Item 1. Business Overview Teladoc Health is the global leader in whole person virtual care, forging a new healthcare experience with better convenience, outcomes, and value. Our mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. Teladoc Health was founded on a simple, yet revolutionary idea: that everyone should have access to the best healthcare, anywhere in the world on their terms. Today, we have a vision of making virtual care the first step on any healthcare journey, and we are delivering on this mission by providing whole person virtual care that includes primary care, mental health, chronic condition management, and more. We have developed and built upon our diverse capabilities over the course of more than 20 years, evolving our product and service portfolio from a suite of point solutions to a whole person offering. We are creating a unified and personalized consumer experience, developing technologies to connect patients and extend the reach of care providers, delivering the highest standard of clinical quality at every touchpoint, and enhancing health decisions and outcomes with smart data and actionable insights. Regardless of people's healthcare needs, across any site of care, we aim to provide the right level of personalized support to meet that need. We believe that we have the largest breadth of integrated whole person products and services in the virtual care industry, enabling us to treat the whole person, from mental healthcare to physical healthcare, and from acute episodic needs to chronic needs. We strive to be the "front door" to the healthcare system for our members, with a unique ability to connect them to the care they need. People who come to us with one of these needs are in turn much more likely to rely on us for other healthcare needs, which creates the opportunity for us to build longitudinal relationships, with care that's personalized for each individual. We aim

View Full Filing

View this 10-K filing on SEC EDGAR